(Q34638892)

3 August 2017

title

Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases (English)

1 reference

3 August 2017

1 reference

M Afshar

1

1 reference

3 August 2017

A D Martinez

series ordinal

2

1 reference

3 August 2017

R L Gallo

series ordinal

3

1 reference

3 August 2017

T R Hata

series ordinal

4

1 reference

3 August 2017

publication date

1 June 2012

1 reference

Journal of the European Academy of Dermatology and Venereology

3 August 2017

published in

1 reference

3 August 2017

volume

27

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

771-778

1 reference

Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy.

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Telaprevir for previously untreated chronic hepatitis C virus infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Interferon-α-conditioned human monocytes combine a Th1-orienting attitude with the induction of autologous Th17 responses: role of IL-23 and IL-12.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Treatment of erythrodermic psoriasis in HCV+ patient with adalimumab.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Diagnosis, management, and treatment of hepatitis C: an update

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Type I interferon: potential therapeutic target for psoriasis?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Antimicrobial peptides and self-DNA in autoimmune skin inflammation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Extensive psoriasis induced by pegylated interferon: a case report

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

The natural history of hepatitis C virus (HCV) infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Cross-regulation of TNF and IFN-alpha in autoimmune diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Psoriasis induced by topical imiquimod

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Etanercept therapy in patients with autoimmunity and hepatitis C.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

The burden of hepatitis C in the United States

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Natural history of hepatitis C.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Hepatitis C virus infection in patients with psoriasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Interferon-alpha-induced psoriasis vulgaris

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Psoriasis with articular involvement induced by interferon alfa

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Exacerbation of psoriasis due to peginterferon alpha-2b plus ribavirin treatment of chronic active hepatitis C.

7 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Psoriasis associated with HCV and exacerbated by interferon alpha: complete clearance with acitretin during interferon alpha treatment for chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Etanercept therapy in two patients with psoriasis and concomitant hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Hepatitis C virus infection in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Increased Sensitivity to Interferon-α in Psoriatic T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Does cyclosporine have a beneficial effect on the course of chronic hepatitis C infection after renal transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Interferon-free treatment regimens for hepatitis C: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Chronic hepatitis C infection and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Autoimmune thyroiditis and delayed onset psoriasis in association with combination therapy for chronic hepatitis C infection.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Overwhelming diffuse psoriasis during chronic HCV infection, after peginterferon-ribavirin treatment, supported by frequent resort to filgrastim rescue

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

New-onset psoriasis following treatment with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Generalized pustular psoriasis and Hepatitis C virus infection.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

Psoriasis and hepatitis C virus

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443510

The Cytokine Network in Lesional and Lesion-Free Psoriatic Skin Is Characterized by a T-Helper Type 1 Cell-Mediated Response

26 October 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04582.X

Exacerbation of psoriasis during alpha-interferon therapy

21 January 2018

1 reference

12 December 2020

Psoriasis is not a contraindication for alpha interferon treatment in patients with chronic hepatitis C

1 reference

12 December 2020

Psoriasis patients generate increased serum levels of autoantibodies to tumor necrosis factor-alpha and interferon-alpha

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis

1 reference

12 December 2020

Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism

1 reference

12 December 2020

[Interferon-alpha and development of psoriatic arthropathy]

1 reference

12 December 2020

Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C

1 reference

12 December 2020

Serum levels of interferons and TNF-alpha are not correlated to psoriasis activity and therapy

1 reference

12 December 2020

Psoriasis associated with hepatitis C but not with hepatitis B

1 reference

12 December 2020

Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant

1 reference

12 December 2020

[IFN-alpha-induced psoriatic arthritis and HCV-related liver cirrhosis. Therapeutic options and patient's opinion]

1 reference

12 December 2020

Effective control of psoriasis by etanercept in a patient with HCV-related diseases

1 reference

12 December 2020

Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis

1 reference

12 December 2020

Psoriatic arthritis with spinal involvement in a patient receiving alpha-interferon for chronic hepatitis C

1 reference

12 December 2020

Generalized flare of pustular psoriasis induced by PEGylated interferon-α2b therapy for chronic hepatitis C

1 reference

12 December 2020

Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro

1 reference

12 December 2020

Verrucous psoriasis in a patient with chronic C hepatitis treated with interferon

1 reference

12 December 2020

Psoriasis and alpha-interferon

1 reference

12 December 2020

Arthritis in a patient with psoriasis after interferon-alpha therapy for chronic hepatitis C

1 reference

12 December 2020

Exacerbation of psoriasis after treatment with alpha-interferon

1 reference

12 December 2020

Interferon in suction blister fluid from psoriatic lesions

1 reference

12 December 2020

Detection of interferon in the sera of patients with psoriasis, and its enhancement by PUVA treatment

1 reference

12 December 2020

Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells

1 reference

12 December 2020

[The exacerbation of psoriasis during treatment with alfa interferon]

1 reference

12 December 2020

Psoriasis exacerbation induced by interferon-alpha. Report of two cases

1 reference

12 December 2020

[The treatment of hepatitis B and C with interferon-alpha can induce or aggravate psoriasis]

1 reference

12 December 2020

Psoriasis induced by interferon-α

1 reference

12 December 2020

CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling

1 reference

12 December 2020

Interferon-induced psoriasis in a patient with chronic hepatitis C

1 reference

12 December 2020

Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept)

1 reference

12 December 2020

Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection

1 reference

12 December 2020

[Pegylated interferon alfa-induced psoriasis]

1 reference

12 December 2020

Chronic active hepatitis associated with etretinate therapy

1 reference

12 December 2020

10.1111/J.1468-3083.2012.04582.X

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference